2 completed. 2 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
| Phase 3 | 1 | Completed 1 |
Follow Ectodermal Dysplasia: new trials by email Literature Review of Ectodermal Dysplasia trials Research Report on Ectodermal Dysplasia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase 2/3 Study Evaluating the Safety and Efficacy of PTX-022 in Treatment of Adults With Pachyonychia Congenita PTX-022, Placebo - Pachyonychia Congenita | Phase 2 / Phase 3 | Completed | Palvella Therapeutics, Inc. | 73 | 2019-04-01 | 2024-08-29 |
| Phase 2 Study to Evaluate Safety, Pharmacokinetics, Immunogenicity and Pharmacodynamics/Efficacy of EDI200 in Male Infants With X-Linked Hypohidrotic Ectodermal Dysplasia (XLHED) EDI200 - X-Linked Hypohidrotic Ectodermal Dysplasia | Phase 2 | Completed | Edimer Pharmaceuticals | 6 | 2013-04-01 | 2016-01-20 |
Ectodermal Dysplasia 1, Anhidrotic (1) · Pachyonychia Congenita (1)
Abnormalities, Multiple (2) · Congenital Abnormalities (2) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Genetic Diseases, Inborn (2) · Skin Abnormalities (2) · Skin Diseases (2) · Skin Diseases, Genetic (2) · Skin and Connective Tissue Diseases (2) · Genetic Diseases, X-Linked (1) · Nail Diseases (1)
Fc-EDA (1)
Edimer Pharmaceuticals (1) · Palvella Therapeutics, Inc. (1)
United States (2) · France (1) · Germany (1) · Italy (1) · United Kingdom (1)
David Hansen, MD (1) · Joyce Teng, MD (1) · Kenneth Huttner, MD, PhD (1)